Home > Healthcare > Pharmaceuticals > Finished Drug Form > Oxytocin Market

Oxytocin Market Size

  • Report ID: GMI9261
  • Published Date: Apr 2024
  • Report Format: PDF

A PHP Error was encountered

Severity: Warning

Message: getimagesize(xytocin Market Size</h2> <p>Oxytocin Market was valued at around USD 85.3 million in 2023 and is estimated to grow at 9.5% CAGR from 2024 to 2032. Oxytocin is a hormone and neurotransmitter produced in the hypothalamus and released by the posterior pituitary gland. It plays a crucial role in various physiological processes particularly in social bonding, childbirth, and lactation. Oxytocin is often referred to as the bonding hormone due to its involvement in social behaviors and emotional connections between individuals.<br width=): failed to open stream: No such file or directory

Filename: v2_reports/body1.php

Line Number: 435

Backtrace:

File: /home/admin/web/gminsights.com/public_html/application/views/v2_reports/body1.php
Line: 435
Function: getimagesize

File: /home/admin/web/gminsights.com/public_html/application/views/v2_layouts/master_header_footer.php
Line: 1251
Function: view

File: /home/admin/web/gminsights.com/public_html/application/controllers/Reports.php
Line: 703
Function: view

File: /home/admin/web/gminsights.com/public_html/index.php
Line: 305
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: getimagesize(xytocin Market Size</h2> <p>Oxytocin Market was valued at around USD 85.3 million in 2023 and is estimated to grow at 9.5% CAGR from 2024 to 2032. Oxytocin is a hormone and neurotransmitter produced in the hypothalamus and released by the posterior pituitary gland. It plays a crucial role in various physiological processes particularly in social bonding, childbirth, and lactation. Oxytocin is often referred to as the bonding hormone due to its involvement in social behaviors and emotional connections between individuals.<br width=): failed to open stream: No such file or directory

Filename: v2_reports/body1.php

Line Number: 435

Backtrace:

File: /home/admin/web/gminsights.com/public_html/application/views/v2_reports/body1.php
Line: 435
Function: getimagesize

File: /home/admin/web/gminsights.com/public_html/application/views/v2_layouts/master_header_footer.php
Line: 1251
Function: view

File: /home/admin/web/gminsights.com/public_html/application/controllers/Reports.php
Line: 703
Function: view

File: /home/admin/web/gminsights.com/public_html/index.php
Line: 305
Function: require_once

Oxytocin Market Size

Oxytocin Market was valued at around USD 85.3 million in 2023 and is estimated to grow at 9.5% CAGR from 2024 to 2032. Oxytocin is a hormone and neurotransmitter produced in the hypothalamus and released by the posterior pituitary gland. It plays a crucial role in various physiological processes particularly in social bonding, childbirth, and lactation. Oxytocin is often referred to as the bonding hormone due to its involvement in social behaviors and emotional connections between individuals.

 

Oxytocin Market

The increasing incidence of pregnancy complications serves as a substantial impetus for the growing demand of pregnancy medications. For instance, according to the data from World Health Organization (WHO), maternal mortality remained high, with approximately 287,000 women lost their lives during and after pregnancy in 2020. The vast majority, nearly 95%, of these tragic deaths occurred in countries classified as low and lower-middle income. Thus, this underscores the significant demand for oxytocin and related maternal healthcare products, highlighting the crucial role they play in addressing pregnancy complications and reducing maternal mortality rates.
 

Furthermore, increase in childbirth rates, growing awareness of induced labor and breastfeeding, and increasing research & development activities are the contributing factors stimulating the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Oxytocin market size was USD 85.3 million in 2023 and is expected to register 9.5% CAGR from 2024-2032 owing to increasing incidence of pregnancy complications along with increase in childbirth rates, and growing awareness of induced labor and breastfeeding worldwide.

Oxytocin industry from the postpartum segment is expected to reach USD 135.4 million by 2032 due to its potential anti-inflammatory properties akin to those found in anti-inflammatory drugs, facilitating postpartum healing and recovery.

The U.S. oxytocin industry is expected to register 9.2% CAGR from 2024-2032 due to rise in childbirth rates and considerable demand for products and services related to childbirth and maternal health in the country.

Ferring Pharmaceuticals, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, Novartis AG, Pfizer Inc., Sun Pharma Industries Limited., Teva Pharmaceutical Industries Ltd., Viatris Inc., Wockhardt Limited, and Yuhan Corporation, are some of the major oxytocin companies worldwide.

Oxytocin Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 150
  • Countries covered: 23
  • Pages: 110
 Download Free Sample